Skip to main content
Home
  • Clinical Outcome Assessments
    Clinical Outcome Assessments

    What are Clinical Outcome Assessments (COAs)? What do they measure?

    Learn more about COAs
    hero_1.jpeg
    The most trusted distributor of COAs

    700+ exclusive COA distributions on behalf of their copyright owners

    hero_2.jpeg
    PROQOLID™: the largest COA database

    7,000+ COAs described in details and accessible in this unique database

  • Services
    Services

    Mapi Research Trust provides turnkey solutions for your Clinical Outcome Assessments (COAs) strategies - including COA databases, targeted literature reviews, licensing.

    Read More
    COA Databases Patient-Centered Endpoint Intelligence COA Licensing Translation and Linguistic Validation eCOA Licensing COA Repository
    hero_3.jpeg
    About ePROVIDE™

    Online access to all our services and COA databases

    hero_2_2.jpeg
    What are eBooklets?

    Find out more about this step-by-step guidance for valid digitization of COAs

  • Author Collaboration
    Author Collaboration

    Our team is dedicated to assisting authors in the daily management of their questionnaires and all derivatives, including translations and electronic versions

    Read More
    COA distribution COA copyright and protection Promotion of COAs and developers Testimonials
    hero_3_1.jpeg
    Catalog of COAs distributed by Mapi Research Trust

    800+ exclusive distributions of COAs, accessible in ePROVIDE

  • Resources
    Resources

    ACCESS all our resources on COAs and eCOA: webinars, publications, blogs. SUBSCRIBE to receive email updates.

    Read More
    Blog Publications Useful links Webinar recordings Whitepapers
    Whitepaper-Digitizing-COAs.jpg
    New whitepaper

    Digitizing COAs: A streamlined approach to approval

    hero_4_2.jpeg
    New whitepaper

    COAs and copyright: How to mitigate risks of infringement and misuse in clinical research and practice

  • News & Events
    News & Events

    Stay informed with our latest news and check all our upcoming events. SUBSCRIBE to get email updates.

    Read More
    hero_5_1.jpeg
    News
    Hero_5_2.jpeg
    Conferences
    Hero_5_3.jpeg
    Webinars
  • About us
    About us

    Mapi Research Trust is a non-profit organization dedicated to improving patients’ quality of life by facilitating access to Clinical Outcome Assessments(COAs).

    Read More
    hero_6_1.jpeg
    Team

    A global team of multi-disciplinary experts

    hero_6_2.jpeg
    Experience

    Collecting & Processing Patient Centered Outcomes information for more than two decades

  • Contact
  1. Home
  2. News & Events
  3. News
  4. Charles Richard Boddington Joyce (August 9, 1923 – August 11, 2015)

Charles Richard Boddington Joyce (August 9, 1923 – August 11, 2015)

by Bernard Jambon, on behalf of all your friends at Mapi and SAC members
Dick,
You did not have permission to die. But once again, as usual, you did not wait to get our permission.
With you, we have lost an extraordinary friend. One who has guided us for 20 years. One who put us back on track or encouraged us to go off the rails. One who, by your humanism and sense of humor, made us laugh and sometimes cry. Most of all, you were the one who always made us question ourselves.
We already miss you tremendously. Through all our memories, you will continue to guide us and make us smile.
“Tchao mon pote.”
Bernard

by Nick Palmer, Director of Policy, European Coalition to End Animal Experiments (ECEAE), British Union for the Abolition of Vivisection (BUAV), and Ismene Joyce
Dick Joyce was a polymath to the point of implausibility, fitting in segments of half a dozen different careers into one very happy life. He grew up during the Second World War decrypting Japanese diplomatic messages at Bletchley Park and moved on to Jerusalem, where he spent 18 months eavesdropping on members of the embryonic Jewish government. On July 22, 1946, he was blown up at the British headquarters at the King David Hotel, where he sustained a back injury that would trouble him for the rest of his life. This traumatic incident in no way diminished his affection for the Jewish and Muslim population of the country that went on to become Israel. Back in England, he then studied Economics at Cambridge, followed by first class Honours in Moral Sciences (as Psychology was then amusingly called, as he observed), followed by a BSc. in Physiology and a Ph.D. in Pharmacology. After a USPHS Fellowship at the University of Cincinnati, he became a Reader in Psychopharmacology at the University of London and joint chairman of the Department of Pharmacology and Therapeutics at the London Hospital Medical College.
With his second wife Ismene, son Nick and daughter Cressida, he was seduced into industry by the offer of leadership of the newly created group for Methodology (later Project Innovation) in the Medical Department of Ciba-Geigy (subsequently Novartis) where the enlightened Swiss management gave him his head to delve into whatever line of enquiry he thought fruitful. Meanwhile, he had become Visiting Professor in the Departments of Psychiatry at the University of Berne, and Psychology at the Royal College of Surgeons in Ireland, as well as a Foreign Associate of the Institute of Cognitive Sciences at the Boulder Campus of the University of Colorado.
At various times, he was a member of UN, WHO, MAPI Research Institute, UK and French advisory boards and Swiss committees on drug dependence, clinical trial methodology, patient and physician compliance, Quality of Life methodology and complementary medicine. He served on the editorial boards of several journals, and himself published more than 200 papers on cell-membrane ionic transport, medical ethics, the effect upon the response to therapeutic interventions of “non-specific factors” such as placebo and individual attributes of physician and patient, as well as editing five books on these and other topics. His passion, however, was a struggle to write poetry and, much later, an autobiography, a novel and short stories. He encouraged everyone around him to explore life – in my case Parliamentary life – and enriched the world around him. His beloved family – wife, son, daughter, daughter-in-law and grandson – survive him.
Towards the end, he reflected, “I’ve led (or been led by) a fantastically happy life. Which parts were influential? Either none, if everything happens by chance; or all, if everything is predetermined.” Dick Joyce finished as he had lived, curious, enquiring and humorous to the end. Some called his sense of humour British. Others knew it to be entirely Dickish.
 

In this section
In this section
  • News
  • Events
    • Conferences
    • Webinars
Site Branding
    ICON plc
  • Contact
  • About Us
For Clients
  • Services
  • Resources
  • ePROVIDE™
News & Events
  • News
  • Conferences
  • Webinars
Socials
  • Linkedin

Legal Footer

  • © 2025 Mapi Research Trust
  • Disclaimer
  • Privacy
How can we help?
  • All
Popular search terms:
  • COVID-19
  • Site & Patient Recruitment
  • Oncology
  • Medical Device
  • Real World Evidence
  • Decentralised & hybrid clinical trials
  • Digital Disruption